Last updated: 2026-09-06 02:48:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Accuray Incorporated (ARAY) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $0.27, with a market capitalization of $31.05M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.22 to $2.10. This page covers its latest market performance, valuation, price trends and company information.
$31.05M | |
$0.27 | |
$31.09 | |
$0.22 | |
$0.27 | |
269.32K | |
-- | |
-- | |
$2.10 | |
$0.22 | |
-- | |
-- |
Accuray Incorporated (ARAY) last closed at $0.27 as of 2026-09-04 23:36:00, unchanged from the previous close of $0.27.
During the latest regular trading session, ARAY traded between $0.22 and $31.09, with a volume of 269.32K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Accuray Incorporated (ARAY) moved from $0.27 to $0.27, representing a decline of 1.48% ($0.00).
The stock traded between $0.26 and $0.27 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 386.45 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 2.4%
ARAY is currently trading at $0.27, placing it 2.4% of the way from its 52-week low of $0.22 to its 52-week high of $2.10. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. The company has one operating segment which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 809 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Accuray Incorporated (ARAY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.